{
  "meta": {
    "title": "213_Medicine_Aiims_2019_May_Nov",
    "url": "https://brainandscalpel.vercel.app/213-medicine-aiims-2019-may-nov-45fc898e.html",
    "scrapedAt": "2025-11-30T12:56:57.468Z"
  },
  "questions": [
    {
      "text": "A 16-year-old girl, who is taking antiepileptics, has had a seizure-free period of 6 months. She has no family history of epilepsy. Her EEG is now normal and she has a normal neurological exam and intelligence. What would your advice be?",
      "choices": [
        {
          "id": 1,
          "text": "Stop the treatment and follow up"
        },
        {
          "id": 2,
          "text": "Gradually taper the drug and stop treatment"
        },
        {
          "id": 3,
          "text": "Continue treatment for another 18 months"
        },
        {
          "id": 4,
          "text": "Continue lifelong treatment with antiepileptics"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the given clinical scenario of a girl on <strong>antiepileptics</strong> for<strong> 6 months</strong> with <strong>no further seizures,</strong> no family history, normal EEG, neurological examination, and intelligence, antiepileptics should be continued for another <strong>18 months</strong> since she&rsquo;s already taken fo<strong>r 6 months (minimum 2 years) </strong>to prevent seizure <strong>recurrence</strong>.</p>\n<p>Anti-epileptic drugs <strong>withdrawal</strong> is considered only when an adult patient has been <strong>seizure-free for &ge;2 years </strong>along with the following <strong>criteria</strong>:</p>\n<ul>\n<li>Normal CNS examination including intelligence</li>\n<li>Normal EEG and normal MRI</li>\n<li>Single seizure type</li>\n<li>No family history of epilepsy.</li>\n</ul>\n<p>It is preferable to reduce the dose of the drug <strong>gradually</strong> over <strong>2&ndash;3 months.</strong></p><p>Other options:</p>\n<p>Option A: <strong>Sudden cessation</strong> of drug therapy may cause <strong>recurrence</strong> of seizure hence not advised.</p>\n<p>Option B: The patient has a seizure-free interval of only 6 months and therefore, is not yet eligible for considering medication withdrawal.</p>\n<p>Option D: Life-long treatment is not necessary in this case as the patient meets all the above-mentioned criteria for drug withdrawal after 2 years.</p>\n<p>Note: <strong>Juvenile myoclonic epilepsy</strong> (JME), the most common idiopathic generalized epilepsy syndrome is known to have a high risk of seizure recurrence, and hence <strong>antiepileptics</strong> are continued <strong>lifelong</strong> in a majority of patients.</p><hr><h3>Related Pearl: First-line Agents in Different Types of Seizures</h3><table>\n<tbody>\n<tr>\n<td><strong>Type of seizure&nbsp;</strong></td>\n<td><strong>1st-line antiepileptic drugs</strong></td>\n</tr>\n<tr>\n<td>\n<p>Focal seizures&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine&nbsp;</li>\n<li>Lamotrigine</li>\n<li>Levetiracetam</li>\n<li>Phenytoin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GTCS&nbsp;</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate</li>\n<li aria-level=\"1\">Levetiracetam&nbsp;</li>\n<li aria-level=\"1\">Lamotrigine&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Typical absence seizures&nbsp;</td>\n<td>\n<ul>\n<li><strong>Ethosuximide&nbsp;</strong>(drug of choice)</li>\n<li>Sodium valproate</li>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Atypical absence seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Myoclonic seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\"><strong>Sodium valproate</strong> (drug of choice)</li>\n<li aria-level=\"1\">Lamotrigine</li>\n<li aria-level=\"1\">Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7033",
      "difficulty": "medium"
    },
    {
      "text": "AKIN  and RIFLE criteria are used to classify",
      "choices": [
        {
          "id": 1,
          "text": "Acute kidney injury"
        },
        {
          "id": 2,
          "text": "Chronic renal failure"
        },
        {
          "id": 3,
          "text": "Acute glomerulonephritis"
        },
        {
          "id": 4,
          "text": "Nephrotic syndrome"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>AKIN</strong> and <strong>RIFLE criteria</strong> are used to <strong>classify acute kidney injury</strong> (AKI).</p>\n<p>The various classifications used in AKI are:</p>\n<ul>\n<li>RIFLE criteria (Risk, Injury, Failure, Loss, End-stage)</li>\n<li>AKIN (AKI Network) Classification</li>\n<li>KDIGO (Kidney Disease Improving Global Outcomes) Classification</li>\n</ul>\n<p><strong>RIFLE, AKIN, KDIGO definitions</strong> of AKI:</p>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td>RIFLE</td>\n<td>AKIN</td>\n<td>KDIGO</td>\n</tr>\n<tr>\n<td>S. creatinine</td>\n<td>&gt;50% increase that develops in &lt;7 days </td>\n<td>&gt;0.3 mg/dl increase or &gt;50% increase that develops in &lt;48hr</td>\n<td>&gt;0.3 mg/dl increase or &gt;50% increase that develops in &lt;7 days</td>\n</tr>\n<tr>\n<td>Urine output</td>\n<td>&lt;0.5ml/kg/hr for &gt;6 hr</td>\n<td>&lt;0.5ml/kg/hr for &gt;6 hr</td>\n<td>&lt;0.5ml/kg/hr for &gt;6 hr</td>\n</tr>\n<tr>\n<td> </td>\n<td> </td>\n<td> </td>\n<td> </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br /><strong>RIFLE, AKIN, KDIGO staging </strong>of AKI:</p>\n<table>\n<tbody>\n<tr>\n<td>RIFLE</td>\n<td>Increase in S.creatinine </td>\n<td>AKIN</td>\n<td>Increase in S.creatinine</td>\n<td>KDIGO</td>\n<td>Increase in S.creatinine</td>\n<td>Urine output</td>\n</tr>\n<tr>\n<td><strong>R</strong>isk </td>\n<td>≥50%</td>\n<td>Stage 1</td>\n<td>≥0.3mg/dl or ≥50%</td>\n<td>Stage 1</td>\n<td>≥0.3mg/dl or ≥50%</td>\n<td>&lt;0.5mL/kg/hr for &gt;6h</td>\n</tr>\n<tr>\n<td><strong>I</strong>njury</td>\n<td>≥100%</td>\n<td>Stage 2</td>\n<td>≥100%</td>\n<td>Stage 2</td>\n<td>≥100%</td>\n<td>&lt;0.5mL/kg/hr for &gt;12 hr</td>\n</tr>\n<tr>\n<td><strong>F</strong>ailure</td>\n<td>≥200%</td>\n<td>Stage 3</td>\n<td>≥200%</td>\n<td>Stage 3</td>\n<td>≥200%</td>\n<td>&lt;0.3mL/kg/hr for &gt;24hr or anuria &gt;12hr</td>\n</tr>\n<tr>\n<td><strong>L</strong>oss</td>\n<td>Need for renal replacement therapy (RRT)&gt;4 weeks</td>\n<td> </td>\n<td> </td>\n<td> </td>\n<td> </td>\n<td> </td>\n</tr>\n<tr>\n<td><strong>E</strong>nd-stage</td>\n<td>Need RRT for &gt;3 months</td>\n<td> </td>\n<td> </td>\n<td> </td>\n<td> </td>\n<td> </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1403",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements about polycythemia vera is true?",
      "choices": [
        {
          "id": 1,
          "text": "Risk of thrombosis strongly correlates with the degree of thrombocytosis"
        },
        {
          "id": 2,
          "text": "Generalized pruritus is a consequence of mast cell activation by JAK 2 mutation"
        },
        {
          "id": 3,
          "text": "It is protective against H.pylori infection"
        },
        {
          "id": 4,
          "text": "Acute myeloid leukemia is the most common cause of mortality"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Generalized pruritus</strong> seen in polycythemia vera (PV) is a consequence of the <strong>activation of mast cells by JAK 2 mutation</strong>.</p>\n<p>Other options:</p>\n<p>Option A: The risk of <strong>thrombosis</strong> strongly correlates with <strong>erythrocytosis</strong>, <strong>not</strong> the <strong>degree of thrombocytosis</strong>.</p>\n<p>Option C: In polycythemia vera, there is an <strong>increased risk of H.pylori infection</strong>.</p>\n<p>Option D: <strong>Thrombosis</strong> is the <strong>major cause of mortality</strong> in polycythemia vera. The incidence of acute leukemia in patients not exposed to chemotherapy or radiation therapy is low.</p>\n<p>PV is a <strong>clonal hematopoietic stem cell disorder</strong> in which red cells, granulocytes &amp; platelets accumulate in the absence of a physiological stimulus. The most common mutation seen in PV is the <strong>JAK2 mutation</strong>.</p><p>Clinical features of polycythemia vera are:</p>\n<ul>\n<li><strong>Thrombosis</strong> is the most common manifestation and is the major cause of mortality. Uncontrolled erythrocytosis causes increased viscosity of the blood causing thrombosis of the vessels. Patients may present with stroke, transient ischemic attacks, myocardial infarction, and Budd-Chiari syndrome.</li>\n<li><strong>Aquagenic pruritis</strong> is generalized itching following a warm bath or a shower due to increased mast cells and histamine.</li>\n<li><strong>Erythromelalgia</strong> is erythema and pain in the fingers, hands, and feet due to increased platelet stickiness.</li>\n<li><strong>Splenomegaly</strong> due to increased destruction of RBCs in the spleen</li>\n<li><strong>Gout</strong> is due to the excessive proliferation of the marrow cells leading to <strong>elevated uric acid levels</strong>.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4291",
      "difficulty": "medium"
    },
    {
      "text": "All of the following are the core clinical features for the diagnosis of Lewy body dementia except:",
      "choices": [
        {
          "id": 1,
          "text": "Fluctuating cognition"
        },
        {
          "id": 2,
          "text": "Recurrent visual hallucination"
        },
        {
          "id": 3,
          "text": "REM sleep behavior disorder"
        },
        {
          "id": 4,
          "text": "Orthostatic hypotension"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Orthostatic hypotension</strong> is <strong>not</strong> a <strong>core </strong>clinical feature of <strong>Lewy body dementia</strong> (LBD) as per <strong>DSM-5</strong>.</p>\n<p><strong>LBD</strong> also known as dementia with Lewy bodies is the second most type of <strong>progressive dementia</strong> after Alzheimer&rsquo;s disease. <strong>Protein deposits</strong>, called <strong>Lewy bodies</strong>, deposit in <strong>nerve cells</strong> in the <strong>brain</strong> region involved in thinking, memory, and movement (motor control)</p>\n<p><strong>Core features</strong> of LBD as per DSM-5 are <strong>fluctuating cognition</strong>, <strong>attention</strong>, <strong>alertness</strong>, <strong>recurrent visual hallucination,</strong> and <strong>Parkinsonian symptoms</strong>. Suggestive features are REM sleep behavior disorder and severe neuroleptic sensitivity.<br />Orthostatic hypotension, erectile dysfunction, and constipation are other features of LBD.</p>\n<p>Treatment of LBD includes <strong>rivastigmine</strong> and <strong>donepezil</strong> which may improve cognition, and reduce hallucinosis and delusion. <strong>Pimavanserin</strong> may be used to treat <strong>psychosis</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9050",
      "difficulty": "medium"
    },
    {
      "text": "A 68-year-old male admitted to the ICU for acute exacerbation of COPD develops a sudden onset of palpitations. The following ECG changes are seen. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Ventricular tachycardia"
        },
        {
          "id": 2,
          "text": "Multifocal atrial tachycardia"
        },
        {
          "id": 3,
          "text": "Atrial fibrillation"
        },
        {
          "id": 4,
          "text": "Atrial tachycardia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario of a <strong>COPD patient</strong> in <strong>ICU</strong> developing <strong>palpitations</strong> and the ECG showing <strong>narrow QRS complex</strong> (&lt;0.12 s) <strong>tachycardia</strong> with more than three <strong>different P wave morphologies</strong>, points to the diagnosis of <strong>multifocal atrial tachycardia</strong> (MAT).</p>\n<p>Multifocal atrial tachycardia (MAT) is characterized by at least <strong>3 distinct P wave morphologies</strong> (shown by arrows in the image) with rates typically between <strong>100 and 150 beats/min</strong>.</p>\n<p>It is usually encountered in patients with <strong>chronic pulmonary disease</strong> and <strong>acute illness</strong>. The clinical features are most commonly related to the underlying precipitating illness (COPD in this case). Unlike atrial fibrillation, there are clear isoelectric intervals between P waves.</p>\n<p><strong>Treating</strong> the <strong>underlying disease</strong> and correcting any metabolic abnormalities is the mainstay of treatment. <strong>Electrical cardioversion</strong> has <strong>no effect</strong>.</p>\n<p>The calcium-channel blockers <strong>verapamil</strong> or <strong>diltiazem</strong> may <strong>slow the atrial and ventricular rate</strong>. MAT may respond to amiodarone, but long-term therapy with this agent is usually avoided due to its toxicities, particularly in pulmonary fibrosis.</p><hr><h3>Related Pearl: Supraventricular tachycardias</h3><p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with narrow QRS complex:</strong></p>\n<ul>\n<li><strong>Narrow QRS with regular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp;Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Sinus tachycardia</strong></td>\n<td>Normal P wave, normal ECG features except for the rate</td>\n</tr>\n<tr>\n<td><strong>Focal atrial tachycardia</strong></td>\n<td>A single type of abnormal p wave morphology is seen</td>\n</tr>\n<tr>\n<td><strong>Junctional tachycardia</strong></td>\n<td>No p waves. Heart rate is 100- 200/ min</td>\n</tr>\n<tr>\n<td><strong>AV nodal reentry tachycardia</strong></td>\n<td>No p waves. Pseudo R' waves may be seen. Heart rate is 150-250/ min</td>\n</tr>\n<tr>\n<td><strong>Atrioventricular reentry tachycardia</strong></td>\n<td>P wave always follows QRS. RP interval&lt; PR interval</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter</strong></td>\n<td>Sawtooth shaped flutter waves are seen</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<ul>\n<li><strong>Narrow QRS with irregular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp; &nbsp; &nbsp;<strong>Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Atrial fibrillation</strong></td>\n<td>No distinct p waves seen</td>\n</tr>\n<tr>\n<td><strong>Multifocal atrial tachycardia</strong></td>\n<td>More than 3 different abnormal p wave morphologies are seen</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter/tachycardia with variable block</strong></td>\n<td>ECG features of heart block are seen.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with wide QRS complex:</strong></p>\n<ul>\n<li>Antidromic AVRT (atrioventricular reentry tachycardia)</li>\n<li>Supraventricular tachycardias with bundle branch block</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/dff48b4c5a7044fc93c59c565f525bc5.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7301",
      "difficulty": "easy"
    },
    {
      "text": "A patient has recurrent optic neuritis of both eyes with extensive transverse myelitis. Visual acuity in the right eye is 6/60 and visual acuity in the left eye 6/18. The patient showed a partial response to steroids. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Neuromyelitis optica"
        },
        {
          "id": 2,
          "text": "Subacute combined degeneration of spinal cord"
        },
        {
          "id": 3,
          "text": "Posterior cerebral artery stroke"
        },
        {
          "id": 4,
          "text": "Neurosyphilis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario of a patient with <strong>recurrent optic neuritis</strong> of both eyes with extensive <strong>transverse myelitis</strong>, showing <strong>partial response to steroids</strong> points to the diagnosis of <strong>neuromyelitis optica</strong> (NMO), also known as <strong>Devic&rsquo;s disease</strong>.</p>\n<p>It is an <strong>aggressive inflammatory demyelinating disorder</strong> characterized by <strong>recurrent attacks </strong>of<strong> optic neuritis </strong>and<strong> myelitis</strong>. Attacks of optic neuritis can be bilateral or unilateral and myelitis can be severe and involve three or more contiguous vertebral segments.</p>\n<p>The core clinical characteristics include <strong>optic neuritis</strong>, <strong>acute myelitis</strong>, <strong>area postrema syndrome</strong> with episodes of otherwise unexplained hiccups or nausea or vomiting, <strong>acute brainstem syndrome</strong>, symptomatic <strong>narcolepsy</strong> or acute diencephalic clinical syndrome with NMOSD-typical diencephalic MRI lesions and symptomatic cerebral syndrome with <strong>NMOSD-typical brain lesions</strong>.</p>\n<p><strong>Acute attacks</strong> of NMO are treated with <strong>high-dose glucocorticoids</strong>. Plasma exchange can be used in acute attacks that do not respond to glucocorticoids.</p>\n<p>Drugs used for <strong>prophylaxis against relapses</strong> include <strong>mycophenolate mofetil</strong>, <strong>rituximab</strong>, <strong>glucocorticoids</strong>, and <strong>azathioprine</strong>. Three<strong> monoclonal antibodies approved</strong> for attack prevention include <strong>eculizumab</strong> (terminal complement inhibitor), <strong>inebilizumab</strong> (B-cell depleter), and <strong>satralizumab</strong> (IL-6 receptor blocker).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7698",
      "difficulty": "easy"
    },
    {
      "text": "Deep y descent in JVP is seen in all except:",
      "choices": [
        {
          "id": 1,
          "text": "Cardiac tamponade"
        },
        {
          "id": 2,
          "text": "Restrictive cardiomyopathy"
        },
        {
          "id": 3,
          "text": "Constrictive pericarditis"
        },
        {
          "id": 4,
          "text": "Tricuspid regurgitation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>y-descent </strong>in jugular venous pulse (JVP) corresponds to the <strong>fall in right atrial pressure</strong> after the tricuspid valve opening in the early diastolic phase of the right ventricle. <strong>Y-descent</strong> is attenuated or<strong> absent </strong>in<strong> cardiac tamponade</strong> because of resistance to ventricular filling in the early diastole.</p>\n<p>Other options:</p>\n<p>Options B and C: <strong>Restrictive cardiomyopathy</strong> and <strong>constrictive pericarditis</strong> can have <strong>deep y descent</strong> due to rapid filling of the right ventricle during early diastole.</p>\n<p>Option D: In patients with <strong>tricuspid regurgitation</strong>, increased blood flow to the right atria through the incompetent tricuspid valve during ventricular systole results in a <strong>prominent v wave</strong>. When the tricuspid valve opens during ventricular diastole, this increased blood in the right atria enters rapidly into the right ventricle during early diastole resulting in <strong>deep y-descent</strong>.</p><hr><h3>Related Pearl: JVP waveform and the abnormalities</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/18bbe4a977c84587903e8637a0d9303cx1280x1005.JPEG\" alt=\"Pearl Image\"><p>1) The <strong>a-wave</strong> corresponds to <strong>atrial contraction</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Prominent a-waves</strong></td>\n<td>Pulmonary hypertension, right atrial thrombus/ mass, and tricuspid stenosis</td>\n</tr>\n<tr>\n<td><strong>Cannon a-waves</strong></td>\n<td>\n<p>Complete AV block, ventricular tachycardia, and premature atrial/ junctional/ ventricular beats</p>\n</td>\n</tr>\n<tr>\n<td><strong>Absent a-waves</strong></td>\n<td>Atrial fibrillation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>2) The <strong>c-wave</strong> corresponds to the <strong>bulging of tricuspid valve</strong> into right atrium during ventricular contraction.</p>\n<p>&nbsp;</p>\n<p>3) The <strong>x-descent</strong> corresponds to <strong>atrial relaxation</strong> during atrial diastole.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Absent x-descent</strong></td>\n<td>Severe tricuspid regurgitation</td>\n</tr>\n<tr>\n<td><strong>Rapid x-descent</strong></td>\n<td>Cardiac tamponade</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>4) The <strong>v-wave</strong> corresponds to the <strong>venous filling</strong> of right atrium.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Dominant v-waves</strong></td>\n<td>Tricuspid regurgitation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>5) The <strong>y-descent</strong> corresponds to the&nbsp;<strong>passive emptying of the right atrium</strong> into right ventricle.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Prolonged y-descent</strong></td>\n<td>Tricuspid stenosis</td>\n</tr>\n<tr>\n<td><strong>Rapid y-descent</strong></td>\n<td>\n<p>Constrictive pericarditis and isolated severe tricuspid regurgitation</p>\n</td>\n</tr>\n<tr>\n<td><strong>Absent y-descent</strong></td>\n<td>Cardiac tamponade</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7697",
      "difficulty": "medium"
    },
    {
      "text": "Tigroid white matter on MR imaging is seen in which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Pantothenate kinase deficiency"
        },
        {
          "id": 2,
          "text": "Pelizaeus-Merzbacher disease"
        },
        {
          "id": 3,
          "text": "Neuroferritinopathy"
        },
        {
          "id": 4,
          "text": "Aceruloplasminemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Tigroid white matter on MR imaging is seen in&nbsp;<strong>Pelizaeus-Merzbacher disease.</strong></p>\n<p>It is a rare, X-linked recessive disorder characterized by central nervous system dysmyelination.</p>\n<p>The proteolipid protein gene (PLP1) is affected, leading to the failure of axon myelination by oligodendrocytes in the central nervous system.</p>\n<p>Clinical Features:</p>\n<ul>\n<li>Nystagmus</li>\n<li>Developmental delay</li>\n<li>Psychomotor delay</li>\n<li>Seizure</li>\n<li>Stridor</li>\n<li>Feeding difficulties</li>\n<li>Ataxia</li>\n<li>Hypotonia progressing to spasticity.</li>\n</ul>\n<p>The degree of dysmyelination is correlated with the severity of the clinical manifestations.</p>\n<p>Genetic analysis can confirm the diagnosis. <strong>MRI </strong>shows a <strong>lack of myelination</strong> and MR spectroscopy reveals aberrant N-acetyl aspartate (NAA) and choline concentrations that reflect axonal and myelination abnormalities.</p>\n<p>Unlike other demyelinating leukodystrophies such as metachromatic leukodystrophy and adrenoleukodystrophy, where myelin is formed but subsequently destroyed, PMD shows a failure of myelin formation.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7700",
      "difficulty": "medium"
    },
    {
      "text": "All of the following characteristics are found in the pleural effusion fluid of a rheumatoid arthritis patient except:",
      "choices": [
        {
          "id": 1,
          "text": "RA factor"
        },
        {
          "id": 2,
          "text": "High glucose"
        },
        {
          "id": 3,
          "text": "Cholesterol crystals"
        },
        {
          "id": 4,
          "text": "High LDH"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Low glucose</strong> (&lt;60 mg/dL) is seen in the <strong>pleural effusion fluid</strong> of a patient with <strong>rheumatoid arthritis</strong> (RA).</p>\n<p><strong>RA</strong> causes <strong>exudative pleural effusion</strong> and fulfills the Light&rsquo;s criteria. <strong>High LDH</strong> and <strong>RA factor</strong> are found in the pleural fluid of RA patients. <strong>Less commonly</strong>, patients with RA may have a <strong>cholesterol effusion</strong>. It is <strong>sterile</strong> and has a <strong>milky </strong>or<strong> opaque appearance</strong>. The milky appearance is due to the presence of cholesterol crystals and an elevated cholesterol level.</p>\n<p><strong>Light&rsquo;s criteria</strong> is used to <strong>distinguish</strong> between<strong> exudative </strong>and<strong> transudative </strong>pleural effusions. An <strong>exudative pleural effusion</strong> satisfies at least <strong>one</strong> of the following <strong>criteria</strong>:</p>\n<ul>\n<li>Pleural fluid protein/serum protein &gt; 0.5</li>\n<li>Pleural fluid LDH / serum LDH &gt; 0.6</li>\n<li>Pleural fluid LDH more than 2/3rds upper limit of normal for serum</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3c76be2af0f04ba88f45ca2174e078fax1280x2296.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Types of pleural effusion</h3><p><strong>Transudative Pleural effusion</strong></p>\n<ul>\n<li>Congestive heart failure (most common)</li>\n<li>Cirrhosis</li>\n<li>Nephrotic syndrome</li>\n<li>Myxedema&nbsp;</li>\n<li>Peritoneal dialysis</li>\n<li>Urinothorax</li>\n<li>Hypoalbuminemia</li>\n<li>Constrictive pericarditis</li>\n<li>Superior vena cava obstruction</li>\n</ul>\n<p><strong>Exudative Pleural effusion&nbsp;</strong></p>\n<ul>\n<li aria-level=\"1\">Infections:&nbsp;Tuberculosis, pneumonia,&nbsp;intraabdominal abscess (like- liver abscess)</li>\n<li aria-level=\"1\">Malignancy:&nbsp;Pleural mesothelioma,&nbsp;metastasis,&nbsp;lymphoma</li>\n<li aria-level=\"1\">Connective tissue diseases:&nbsp;SLE,&nbsp;rheumatoid arthritis</li>\n<li aria-level=\"1\">Drugs:&nbsp;Amiodarone,&nbsp;bromocriptine,&nbsp;dantrolene,&nbsp;dasatinib,&nbsp;methysergide,&nbsp;nitrofurantoin</li>\n<li aria-level=\"1\">Others:\n<ul>\n<li aria-level=\"1\">Pancreatitis</li>\n<li aria-level=\"1\">Asbestosis</li>\n<li aria-level=\"1\">Pulmonary embolism</li>\n<li aria-level=\"1\">Hemothorax</li>\n<li aria-level=\"1\">Chylothorax</li>\n<li aria-level=\"1\">Meigs' syndrome&nbsp;</li>\n<li aria-level=\"1\">Dressler syndrome (post-myocardial infarction or cardiac surgery)</li>\n<li aria-level=\"1\">Yellow nail syndrome&nbsp;</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7695",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common pulmonary manifestation of SLE?",
      "choices": [
        {
          "id": 1,
          "text": "Shrinking lung syndrome"
        },
        {
          "id": 2,
          "text": "Pleuritis"
        },
        {
          "id": 3,
          "text": "Intra alveolar hemorrhage"
        },
        {
          "id": 4,
          "text": "Interstitial inflammation"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The most common pulmonary manifestation of SLE is <strong>pleuritis</strong>, with or without pleural effusion.</p>\n<p>The most common manifestations of different systems involved in SLE are:</p>\n<ul>\n<li>Musculoskeletal- arthritis and arthralgia</li>\n<li>Skin- photosensitivity</li>\n<li>Kidneys- proteinuria</li>\n<li><strong>Neurologic- cognitive impairment</strong></li>\n<li><strong>Cardiac- pericarditis</strong></li>\n<li>Pulmonary- pleuritis</li>\n<li><strong>Hematologic- anemia</strong></li>\n</ul><hr><h3>Related Pearl: Antibodies in Systemic lupus erythematosus (SLE)</h3><table>\n<tbody>\n<tr>\n<td><strong>Antibody</strong></td>\n<td><strong>Prevelance %</strong></td>\n<td><strong>Antigen Recognized</strong></td>\n<td><strong>Clinical utility</strong></td>\n</tr>\n<tr>\n<td>Antinuclear Antibody</td>\n<td>98</td>\n<td>Multiple nuclear</td>\n<td>Best screening test; repeated -ve test make SLE unlikely</td>\n</tr>\n<tr>\n<td>Anti dS-DNA</td>\n<td>70</td>\n<td>DNA(double stranded)</td>\n<td>High titres are SLE specific &amp; in some patients correlates  with disease activity, nephritis &amp; vasculitis</td>\n</tr>\n<tr>\n<td>Anti-Sm</td>\n<td>25</td>\n<td>Protein complexed to 6 species of nuclear U1 RNA</td>\n<td>Specific for SLE; no definite correlations; most patients also have anti RNP <br />More common in black &amp; asians than white</td>\n</tr>\n<tr>\n<td>Anti-RNP</td>\n<td>40</td>\n<td>Protein complexed to U1 RNA</td>\n<td>Not Specific for SLE; high titre associated with syndromes that have overlap features of several rheumatic syndromes including SLE;<br />More common in blacks and whites </td>\n</tr>\n<tr>\n<td>Anti-Ro( SS-A)</td>\n<td>30</td>\n<td>Protein complexed to hY RNA,<br />Primarily 60kDA and 52kDA</td>\n<td>Not Specific for SLE; associated with sicca syndrome, predisposes to subacute cutaneous lupus &amp; to neonatal lupus with congenital heart block; associated with decrease risk of nephritis</td>\n</tr>\n<tr>\n<td>Anti-La( SS-B)</td>\n<td>10</td>\n<td>47kDa protein complexed to hY RNA</td>\n<td>Usually associated with anti-RO, associated with decreased  risk for nephritis</td>\n</tr>\n<tr>\n<td>Antihistone</td>\n<td>70</td>\n<td>Histones associated with DNA<br />(In nucleosome &amp; chromatin)</td>\n<td>More frequent in drug induced lupus than in SLE</td>\n</tr>\n<tr>\n<td>Antiphospholipid</td>\n<td>50</td>\n<td>Phospholipid,β2 glycoprotein1(β2 G1) cofactor , prothrombin</td>\n<td>3 tests available-ELISAs for cardiolipin &amp; β2 G1,<br />Sensitive prothrombin time (DRVVT)<br />Predisposes to clotting, fetal loss, thrombocytopenia</td>\n</tr>\n<tr>\n<td>Antierythrocyte</td>\n<td>60</td>\n<td>Erythrocyte membrane </td>\n<td> Measured as direct Coombs test , a small proportion devlop overt hemolysis</td>\n</tr>\n<tr>\n<td>Antiplatelet</td>\n<td>30</td>\n<td>Surface &amp; altered cytoplasmic antigens on platelets</td>\n<td>Associated with thrombocytopenia, but sensitivity &amp; specificity are not good:<br />This is not a useful clinical test</td>\n</tr>\n<tr>\n<td>Antineuronal<br />(includes antiglutamate receptor)</td>\n<td>60</td>\n<td>Neuronal &amp; lymphocyte surface antigens</td>\n<td>In some series, a positive test in CSF correlates with active CNS lupus</td>\n</tr>\n<tr>\n<td>Antiribosomal P</td>\n<td>20</td>\n<td>Protein in ribosomes</td>\n<td>In some series, a positive test serum correlates with depression or psychosis due to CNS lupus</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7696",
      "difficulty": "easy"
    },
    {
      "text": "True about the definition of Postural Hypotension:",
      "choices": [
        {
          "id": 1,
          "text": "Decrease in Systolic blood pressure 20 mmHg after 6 mins of standing"
        },
        {
          "id": 2,
          "text": "Decrease in Systolic blood pressure 20 mmHg after 3 min of standing"
        },
        {
          "id": 3,
          "text": "Decrease in Diastolic blood pressure 20 mmHg after 6 mins of standing"
        },
        {
          "id": 4,
          "text": "Decrease in diastolic blood pressure 20 mmHg after 3 mins of standing"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Orthostatic hypotension or postural hypotension is defined as a <strong>sustained drop in systolic BP of &ge;20 mmHg</strong> or <strong>diastolic BP of &ge;10 mmHg</strong> after <strong>3 min of standing</strong>.</p>\n<p>It can manifest as lightheadedness/dizziness, weakness or tiredness, difficulty thinking/concentrating, blurred vision, and anxiety.</p>\n<p>In <strong>non-neurogenic causes</strong> of orthostatic hypotension such as hypovolemia, the drop in the blood pressure is accompanied by a compensatory <strong>increase in heart rate of &gt;15</strong> <strong>beats/min</strong>. In neurogenic causes, there is aggravation or precipitation of orthostatic hypotension by autonomic stressors like a meal, hot bath, or exercise.</p>\n<p><strong>Non-neurogenic causes</strong> of orthostatic hypotension include</p>\n<ul>\n<li>Cardiac pump failure - myocardial infarction, myocarditis, aortic stenosis</li>\n<li>Hypovolemia - dehydration, diarrhea, hemorrhage</li>\n<li>Metabolic - adrenocortical insufficiency, pheochromocytoma</li>\n<li>Venous pooling - sepsis, prolonged standing, or recumbency</li>\n<li>Medications - alpha-blockers, diuretics, phenothiazines, tricyclic antidepressants</li>\n</ul>\n<p><strong>Treatment</strong> includes <strong>removing reversible causes</strong> like <strong>drugs causing hypotension</strong>. Non-pharmacological interventions include <strong>patient education</strong> regarding staged moves from supine to upright, raising the head of the bed, and increasing dietary fluid and salt. If these fail, drugs like <strong>fludrocortisone</strong> and <strong>midodrine</strong> can be given.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7693",
      "difficulty": "medium"
    },
    {
      "text": "The given pattern of EEG is found in:",
      "choices": [
        {
          "id": 1,
          "text": "Hepatic encephalopathy"
        },
        {
          "id": 2,
          "text": "Creuzfeldt-Jakob Disease"
        },
        {
          "id": 3,
          "text": "Generalized tonic clonic seizures"
        },
        {
          "id": 4,
          "text": "Herpes simplex encephalitis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Periodic sharp-wave complexes seen as spikes are seen in <strong>Creutzfeldt-Jakob disease</strong> (CJD).</p>\n<p>It is a <strong>spongiform encephalopathy</strong> that is characterized by rapidly progressive <strong>dementia, myoclonus, akinetic mutism</strong>, cerebellar/visual disturbances. Caused by <strong>Prions</strong>. It is fatal and death occurs usually within a year or less from the onset.</p>\n<p>EEG shows characteristic <strong>periodic sharp wave complexes</strong> (bi/triphasic). CSF assay is positive for <strong>14-3-3 protein</strong>.</p>\n<p>Four types of Creutzfeldt-Jakob disease have been described:</p>\n<ol>\n<li>Sporadic (sCJD): Accounts for 85-90% of cases\n<ul>\n<li>MRI shows <strong>cortical ribbon sign</strong></li>\n</ul>\n</li>\n<li>Variant (vCJD): mad cow disease, Kuru\n<ul>\n<li>MRI shows <strong>hockey stick sign</strong></li>\n</ul>\n</li>\n<li>Familial (fCJD): 10% of cases (these individuals carry a PRPc mutation)</li>\n<li>Iatrogenic</li>\n</ol>\n<p>Option A: <strong>Hepatic encephalopathy</strong> will show a <strong>triphasic wave pattern</strong> (negative-positive-negative wave). They are also seen in Hashimoto encephalopathy and CO<sub>2</sub> narcosis.</p>\n<p>Option C: <strong>GTCS</strong> (generalized tonic clonic seizures)will show <strong>high voltage bursts</strong> &amp; high voltage spikes present in <strong>all</strong> the <strong>leads</strong>.</p>\n<p>Option D: <strong>HSV encephalitis</strong> usually affects one side temporal lobe showing a characteristic <strong>periodic lateralised epiletptiform discharge</strong>.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/af07286f85de4f3dbbda141e1975c166.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7694",
      "difficulty": "medium"
    },
    {
      "text": "Calculate the anion gap from the following values:\nNa+ = 137 mmol/L\nK+ = 4 mmol/L\nCl- = 100 mmol/L\nHCO3- = 15 mmol/L",
      "choices": [
        {
          "id": 1,
          "text": "22 mmol/L"
        },
        {
          "id": 2,
          "text": "16 mmol/L"
        },
        {
          "id": 3,
          "text": "10 mmol/L"
        },
        {
          "id": 4,
          "text": "12 mmol/L"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The anion gap is the <strong>difference between measured cations and measured anions</strong> and is estimated as:</p>\n<p><strong>Anion gap = [Na+] – ([Cl-] + [HCO3-])</strong></p>\n<p>Substituting the given values, AG is 22 mmol/L. <strong>Normal AG</strong> is <strong>6 to 12 mmol/L</strong> with an average of 10 mmol/L.</p>\n<p>The concentrations of anions and cations in plasma must be equal to maintain electrical neutrality. Therefore, there is no real “anion gap” in the plasma.</p>\n<p>However, only certain cations and anions are routinely measured in the clinical laboratory. The <strong>cation normally measured </strong>is<strong> Na+</strong>, and the <strong>anions</strong> are usually <strong>Cl−</strong> and <strong>HCO3−</strong>. The value of plasma potassium is omitted from the calculation of the anion gap.</p>\n<p>Usually, the <strong>unmeasured anions exceed the unmeasured cations</strong>.</p>\n<p>The anion gap will increase if unmeasured anions rise or if unmeasured cations fall.</p>\n<p>The <strong>unmeasured anions</strong> include <strong>albumin</strong>,<strong> phosphate</strong>,<strong> sulfate</strong>, and other organic anions. The <strong>unmeasured cations</strong> include <strong>calcium</strong>,<strong> magnesium</strong>, and<strong> potassium</strong>.</p><hr><h3>Related Pearl: Causes of Metabolic Acidosis</h3><table>\n<tbody>\n<tr>\n<td>High Anion-Gap Metabolic Acidosis (MUDPILES)</td>\n<td>Normal Anion-Gap Metabolic Acidosis (FUSED CAR)</td>\n</tr>\n<tr>\n<td><strong>M</strong>ethanol</td>\n<td><strong>F</strong>istula pancreatic</td>\n</tr>\n<tr>\n<td><strong>U</strong>remia (Renal failure - Acute or Chronic)</td>\n<td><strong>U</strong>reterosigmoidostomy</td>\n</tr>\n<tr>\n<td><strong>D</strong>iabetic ketoacidosis</td>\n<td><strong>S</strong>mall bowel fistula</td>\n</tr>\n<tr>\n<td><strong>P</strong>araldehyde</td>\n<td><strong>E</strong>xtra chloride (Hyperalimentation)</td>\n</tr>\n<tr>\n<td><strong>I</strong>ron tablets, INH</td>\n<td><strong>D</strong>iarrhea</td>\n</tr>\n<tr>\n<td><strong>L</strong>actic acidosis</td>\n<td><strong>C</strong>arbonic anhydrase inhibitor (acetazolamide)</td>\n</tr>\n<tr>\n<td><strong>E</strong>thylene glycol</td>\n<td><strong>A</strong>ddison's disease</td>\n</tr>\n<tr>\n<td><strong>S</strong>alicylates</td>\n<td><strong>R</strong>enal tubular acidosis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7691",
      "difficulty": "easy"
    },
    {
      "text": "The  ECG of a patient who presented to the ER is as given below. The patient was already given a carotid massage and IV Adenosine but the BP is currently 60/30 mm Hg. What is the next best step of management?",
      "choices": [
        {
          "id": 1,
          "text": "Repeat Inj adenosine 6 mg"
        },
        {
          "id": 2,
          "text": "Inj amiodarone 300 mg"
        },
        {
          "id": 3,
          "text": "Synchronised cardioversion"
        },
        {
          "id": 4,
          "text": "Defibrillation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given <strong>ECG</strong> showing <strong>narrow QRS complex</strong> (&lt;0.12 s) tachycardia with <strong>absent P wave</strong> is suggestive of <strong>paroxysmal ventricular tachycardia</strong> (PSVT). The next best step in the management of a patient with <strong>unstable vitals</strong> (systolic blood pressure &lt; 90 mm Hg) is <strong>synchronized cardioversion</strong>.</p>\n<p><strong>Synchronized cardioversion</strong> is the <strong>treatment of choice</strong> in <strong>unstable PSVT</strong> patients, in which shocks are delivered with the defibrillator/monitor in synchronized mode with an initial energy level of <strong>100J</strong>. Synchronization times the delivery so that it is given at the <strong>peak of the QRS complex</strong>.</p>\n<p>If the shock occurs in the ST segment or the T wave (unsynchronized), it can precipitate a more serious arrhythmia such as ventricular fibrillation.</p>\n<table>\n<tbody>\n<tr>\n<td>Synchronized cardioversion</td>\n<td>Defibrillation</td>\n</tr>\n<tr>\n<td>\n<p>Used in <strong>unstable PSVT</strong>, atrial flutter, atrial fibrillation, and ventricular tachycardia <strong>with a pulse</strong></p>\n</td>\n<td>Used in ventricular tachycardia <strong>without pulse</strong> and ventricular fibrillation.</td>\n</tr>\n<tr>\n<td>Shock is delivered in sync with the R wave (in absolute refractory period)</td>\n<td>Shock is delivered at any time during the cardiac cycle.</td>\n</tr>\n<tr>\n<td>\n<p>Monophasic: 100-200 J</p>\n<p>Biphasic: 50-100 J</p>\n</td>\n<td>\n<p>Monophasic: 360 J</p>\n<p>Biphasic:120-200 J</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><p>Other options:</p>\n<p>Option A: In the absence of hemodynamic instability, a repeat dose of injection adenosine (maximum of 12mg) could be attempted.<br /><br />Option B: IV Amiodarone is rarely used in the acute management of PSVT. Instead, it is used as an alternative to calcium channel blockers in chronic suppressive therapy.<br /><br />Option D: Defibrillation is only done for ventricular fibrillation and pulseless ventricular tachycardia.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8f6eebe7c13e4b80ad47f6d86d107833x1280x1845.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Supraventricular tachycardias</h3><p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with narrow QRS complex:</strong></p>\n<ul>\n<li><strong>Narrow QRS with regular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp;Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Sinus tachycardia</strong></td>\n<td>Normal P wave, normal ECG features except for the rate</td>\n</tr>\n<tr>\n<td><strong>Focal atrial tachycardia</strong></td>\n<td>A single type of abnormal p wave morphology is seen</td>\n</tr>\n<tr>\n<td><strong>Junctional tachycardia</strong></td>\n<td>No p waves. Heart rate is 100- 200/ min</td>\n</tr>\n<tr>\n<td><strong>AV nodal reentry tachycardia</strong></td>\n<td>No p waves. Pseudo R' waves may be seen. Heart rate is 150-250/ min</td>\n</tr>\n<tr>\n<td><strong>Atrioventricular reentry tachycardia</strong></td>\n<td>P wave always follows QRS. RP interval&lt; PR interval</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter</strong></td>\n<td>Sawtooth shaped flutter waves are seen</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<ul>\n<li><strong>Narrow QRS with irregular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp; &nbsp; &nbsp;<strong>Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Atrial fibrillation</strong></td>\n<td>No distinct p waves seen</td>\n</tr>\n<tr>\n<td><strong>Multifocal atrial tachycardia</strong></td>\n<td>More than 3 different abnormal p wave morphologies are seen</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter/tachycardia with variable block</strong></td>\n<td>ECG features of heart block are seen.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with wide QRS complex:</strong></p>\n<ul>\n<li>Antidromic AVRT (atrioventricular reentry tachycardia)</li>\n<li>Supraventricular tachycardias with bundle branch block</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/5a0af74b75f84142932d59b67db74053.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0221",
      "difficulty": "medium"
    },
    {
      "text": "Identify the diagnosis.",
      "choices": [
        {
          "id": 1,
          "text": "Facial nerve palsy"
        },
        {
          "id": 2,
          "text": "Plexiform neurofibromatosis"
        },
        {
          "id": 3,
          "text": "Masticator space abscess"
        },
        {
          "id": 4,
          "text": "Fibrous dysplasia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given image showing <strong>thickening of tissues</strong> in the <strong>temporal</strong> and <strong>orbital regions</strong> with <strong>coarse overlying skin</strong> suggests a diagnosis of <strong>plexiform neurofibroma</strong>.</p>\n<p>Plexiform neurofibroma represents an <strong>uncommon variant</strong> (30%) of <strong>neurofibromatosis 1</strong> (NF1). Plexiform neurofibromas are usually evident at birth and result from a <strong>diffuse thickening of nerve trunks</strong> and surrounding tissues that are usually located in the orbital or temporal region of the face. The skin overlying it may be coarse and associated with <strong>hyperpigmentation</strong>.</p>\n<p>Plexiform neurofibromas may produce an overgrowth of an extremity and a deformity of the corresponding bone.</p>\n<p>NF1 is clinically diagnosed when any <strong>2 of the following 7 feature</strong>s are present:</p>\n<ul>\n<li><strong>Six or more caf&eacute;-au-lait macules &gt;5mm</strong> in prepubertal and <strong>&gt;15mm</strong> in postpubertal</li>\n<li>Axillary or inguinal freckling</li>\n<li>Two or more iris lisch nodules</li>\n<li>Two or more neurofibromas or one plexiform neurofibroma</li>\n<li>A distinctive osseous lesion such as sphenoid dysplasia or cortical thinning of long bones with or without pseudoarthrosis.</li>\n<li>Optic gliomas</li>\n<li>A first-degree relative with NF-1</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d83204ea21db457093a030f069e89204.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0222",
      "difficulty": "easy"
    },
    {
      "text": "What is the most common presentation of inhalational anthrax?",
      "choices": [
        {
          "id": 1,
          "text": "Atypical pneumonia"
        },
        {
          "id": 2,
          "text": "Hemorrhagic mediastinitis"
        },
        {
          "id": 3,
          "text": "Lung abscess"
        },
        {
          "id": 4,
          "text": "Broncho pulmonary pneumonia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The most common presentation of inhalation anthrax is <strong>hemorrhagic mediastinitis</strong>, which is seen in 38% of the patients.</p>\n<p><strong>Inhalational anthrax</strong> also known as <strong>wool sorter&rsquo;s disease</strong> is caused by <strong><em>Bacillus anthracis</em></strong>. Infection usually occurs among workers handling contaminated animal wool, hair, and skin in textile and tanning industries.</p>\n<p>Patients present with malaise, fever, cough, shortness of breath &amp; headache. <em>B. anthracis</em> spores are phagocytosed by alveolar macrophages and transported to mediastinal lymph nodes. <strong>Hemorrhagic necrosis</strong> of the <strong>thoracic lymph nodes</strong> draining the lung results in <strong>hemorrhagic mediastinitis</strong>. <strong>Pulmonary infiltrates</strong>, <strong>mediastinal widening</strong>, and <strong>pleural effusion</strong> are other findings.</p>\n<p>Treatment of inhalation anthrax includes a combination of <strong>intravenous ciprofloxacin and clindamycin</strong> for at least <strong>14 days</strong>, <strong>antitoxins</strong> (Raxibacumab, Obiltoxaximab), <strong>anthrax immunoglobulins</strong> and <strong>steroids</strong> (if associated meningitis is present).</p>\n<p><strong>Prophylaxis</strong> with <strong>ciprofloxacin</strong> (500mg twice daily for 2 months) is recommended for anyone at high risk of inhalational exposure to anthrax spores.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0223",
      "difficulty": "medium"
    },
    {
      "text": "A patient of hemophilia received multiple blood transfusions. Which of the following metabolic abnormalities can be seen in a patient?",
      "choices": [
        {
          "id": 1,
          "text": "Metabolic alkalosis"
        },
        {
          "id": 2,
          "text": "Respiratory alkalosis"
        },
        {
          "id": 3,
          "text": "Metabolic acidosis"
        },
        {
          "id": 4,
          "text": "Respiratory acidosis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Among the given options, the <strong>metabolic abnormality</strong> seen in a patient who has received <strong>multiple blood transfusions</strong> is <strong>metabolic alkalosis</strong>.</p>\n<p>This is because the <strong>excess sodium citrate</strong> (anticoagulant) in the transfused blood gets <strong>converted to bicarbonate</strong> leading to <strong>metabolic alkalosis</strong>. Each mmol of citrate generates 3 mEq of bicarbonate (a total of 23 mEq of bicarbonate due to each unit of blood).</p>\n<p>Metabolic acidosis can also be seen in multiple blood transfusions as citrate is acidic, but <strong>metabolic alkalosis</strong> is <strong>more common</strong>.</p><hr><h3>Related Pearl: Complications of a Massive Transfusion</h3><p><strong>Massive transfusion (MT)</strong>&nbsp;is defined as the replacement by transfusion of <strong>10 units of pRBCs</strong>&nbsp;in <strong>24 hours&nbsp;</strong>or more than <strong>4 units of pRBCs</strong> in <strong>one hour</strong>.</p>\n<p>Complications from massive transfusion include:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Complication</strong></td>\n<td><strong>Mechanism</strong></td>\n</tr>\n<tr>\n<td>Hypothermia</td>\n<td>As blood products are normally stored between 1&deg;C and 6&deg;C</td>\n</tr>\n<tr>\n<td>Coagulopathy</td>\n<td>\n<p>MT with PRBCs alone causes a <strong>dilutional coagulopathy&nbsp;</strong>(vs&nbsp;consumptive coagulopathy caused by&nbsp;massive hemorrhage)</p>\n<p>Can be prevented by starting early transfusion of FFP, platelets, pRBCs in a <strong>1:1:1 ratio</strong></p>\n</td>\n</tr>\n<tr>\n<td>Acidosis/ Alkalosis</td>\n<td>\n<p>Mild acidosis - increased CO2 levels in stored blood by 21-35 days</p>\n<p>Metabolic alkalosis -&nbsp;citrate gets metabolized to bicarbonate</p>\n<p>Metabolic acidosis - due to tissue hypoperfusion</p>\n</td>\n</tr>\n<tr>\n<td>Hyperkalemia/ Hypokalemia</td>\n<td>\n<p>Initially - Hyperkalemia, as stored blood has high K+ levels due to inactivated Na/K/ATPase pump</p>\n<p>Later - Hypokalemia, due to intracellular potassium uptake and metabolic alkalosis</p>\n</td>\n</tr>\n<tr>\n<td>Hypocalcemia</td>\n<td>Stored blood is anticoagulated with citrate, which binds calcium.</td>\n</tr>\n<tr>\n<td>Hypomagnesemia</td>\n<td>Infusion of large volumes of magnesium-poor fluids and&nbsp;binding of magnesium to citrate</td>\n</tr>\n<tr>\n<td>Impaired O2-carrying capacity of hemoglobin</td>\n<td>Decreased 2, 3 DPG</td>\n</tr>\n<tr>\n<td>Volume overload</td>\n<td>Due to massive transfusion</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0224",
      "difficulty": "medium"
    },
    {
      "text": "A patient with renal failure develops vomiting in ICU. ABG analysis showed pH - 7.4, Na+ = 145 mEq/L, Cl- = 100 mEq/L, HCO3- =  24 mEq/L, PaCO2 = 40 mmHg. What is the likely metabolic abnormality?",
      "choices": [
        {
          "id": 1,
          "text": "Normal ABG"
        },
        {
          "id": 2,
          "text": "Normal anion gap, metabolic acidosis"
        },
        {
          "id": 3,
          "text": "High anion gap metabolic acidosis with metabolic alkalosis"
        },
        {
          "id": 4,
          "text": "High anion gap metabolic alkalosis with normal metabolic acidosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The likely metabolic abnormality in this patient is <strong>high anion gap metabolic acidosis with metabolic alkalosis</strong>.</p>\n<p>Patients with <strong>renal failure</strong> may have <strong>metabolic acidosis</strong> and <strong>associated vomiting</strong> in this patient may cause <strong>metabolic alkalosis</strong>. However, the parameters of <strong>arterial blood gas</strong> analysis appear to be <strong>normal</strong>. This disparity raises the suspicion of a <strong>mixed acid-base disorder</strong>.</p>\n<p>When <strong>metabolic acidosis and metabolic alkalosis coexist</strong> in the same patient, <strong>pH</strong> may be in the <strong>normal range</strong>. In such cases, the presence of an <strong>elevated anion gap</strong> denotes the presence of <strong>metabolic acidosis</strong>.</p>\n<p>The anion gap (AG) is calculated as:</p>\n<p>AG = [Na+] &ndash; ([Cl-] + [HCO3-])</p>\n<p>= 145-(100+24)</p>\n<p>= 21</p>\n<p>AG is high, which points to <strong>high AG metabolic acidosis</strong>.</p>\n<p>In high anion gap metabolic acidosis, excess H+ ions are buffered by bicarbonate and the bicarbonate level falls. The fall in HCO3- is expected to be equal to the rise in anion gap. The difference between the rise in anion gap and the fall in HCO3- (delta gap) is zero in simple HAGMA.</p>\n<p>Delta gap = (Actual anion gap - Normal anion gap) - (Normal bicarbonate - Actual bicarbonate)</p>\n<p>Associated vomiting in this patient results in loss of acid and hence the fall of bicarbonate level is less compared to the rise in the anion gap. A <strong>delta gap</strong> of <strong>more than +6</strong> indicates the presence of <strong>additional metabolic alkalosis</strong>.</p>\n<p>In this case, the <strong>delta gap </strong>is<strong> 10</strong>, which points to <strong>metabolic alkalosis</strong> in addition to <strong>high AG metabolic acidosis</strong>.</p><hr><h3>Related Pearl: Acid-Base Balance - Normal Values</h3><table>\n<tbody>\n<tr>\n<td>Component</td>\n<td>Normal Range</td>\n<td>Optimal Value</td>\n</tr>\n<tr>\n<td>pH</td>\n<td>7.35 - 7.45</td>\n<td>7.4</td>\n</tr>\n<tr>\n<td>HCO<sub>3</sub><sup>-</sup>&nbsp;</td>\n<td>22 - 28 mEq/L&nbsp;</td>\n<td>&nbsp;24 mEq/L</td>\n</tr>\n<tr>\n<td>pCO<sub>2</sub></td>\n<td>35 - 45 mmHg</td>\n<td>40 mmHg&nbsp;</td>\n</tr>\n<tr>\n<td>Anion gap</td>\n<td>6 - 12 mEq/L</td>\n<td>&lt;10 mEq/L</td>\n</tr>\n<tr>\n<td>O<sub>2</sub> saturation</td>\n<td colspan=\"2\">&gt; 95%</td>\n</tr>\n<tr>\n<td>pO<sub>2</sub></td>\n<td colspan=\"2\">75 - 100 mmHg&nbsp;&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Interpretation of Acid-Base Disorders</h3><table>\n<tbody>\n<tr>\n<td>\n<p>pH&lt;7.35 is acidosis</p>\n<p>pH&gt;7.45 is alkalosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A primary change in HCO<sub>3</sub><sup>-</sup> is termed metabolic</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>If the change in HCO<sub>3</sub><sup>-</sup>&nbsp;is in keeping with the pH (i.e. if there are acidosis and HCO<sub>3</sub><sup>-</sup>&nbsp;is decreased) the problem is metabolic.</p>\n<p>If the change in HCO<sub>3</sub><sup>-</sup>&nbsp;is opposite with the pH (i.e. if there is acidosis and HCO<sub>3</sub><sup>-</sup>&nbsp;is increased or normal) the problem is compensatory metabolic.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A primary change in CO<sub>2 </sub>is termed as respiratory</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>If the change in CO<sub>2 </sub>keeping in line with the pH (if in acidosis CO2 is raised) the problem is termed respiratory</p>\n<p>If the change in CO<sub>2</sub> is in the opposite direction of that of the pH (i.e. if there&nbsp;are acidosis and CO<sub>2</sub> is decreased or normal ) the problem is termed compensatory respiratory</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0225",
      "difficulty": "medium"
    },
    {
      "text": "A 56-year-old woman presented with a gradually diminishing visual field. She was found to have a pituitary mass and underwent trans-sphenoidal hypophysectomy. Now she has low levels of ACTH, TSH, FSH, and LH. Which of the following hormone supplements is not needed in the patient postoperatively?",
      "choices": [
        {
          "id": 1,
          "text": "Mineralocorticoids"
        },
        {
          "id": 2,
          "text": "Thyroid hormones"
        },
        {
          "id": 3,
          "text": "Glucocorticoids"
        },
        {
          "id": 4,
          "text": "Estradiol"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario describes a woman presenting with <strong>hypopituitarism</strong> <strong>following trans-sphenoidal resection</strong>. <strong>Mineralocorticoid supplementation</strong> is <strong>not</strong> needed <strong>postoperatively</strong> as it is <strong>regulated by</strong> the <strong>renin-angiotensin-aldosterone system</strong> and <strong>not</strong> by <strong>ACTH</strong>. Therefore, mineralocorticoid levels would remain intact despite ACTH deficiency.</p>\n<p><strong>Thyroid hormone</strong>, <strong>estradiol</strong>, and <strong>glucocorticoid supplementation</strong> are needed in this patient as their secretion is regulated by anterior pituitary hormones.</p>\n<p>Features of hypopituitarism include <strong>growth abnormalities in children</strong> with a growth hormone deficiency, insufficient levels of gonadotropins leading to <strong>menstrual irregularities</strong>, <strong>infertility</strong> in women and <strong>reduced sexual function</strong>, infertility and <strong>loss of secondary sexual characteristics </strong>in<strong> men</strong>. TSH deficiency leads to stunted growth in children and features of hypothyroidism in both children and adults. ACTH deficiency leads to secondary adrenal insufficiency.</p>\n<p>Polyuria and polydipsia may be seen and indicate a loss of vasopressin secretion in posterior pituitary lesions.</p>\n<p>The following hormones must be replaced post-hypophysectomy:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Trophic hormone deficit</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hormone Replacement</p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ACTH</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hydrocortisone, cortisone acetate, prednisone&nbsp;</p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>TSH</td>\n<td>\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>L-thyroxine (75&ndash;150 &micro;g daily)</p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>FSH/LH</td>\n<td>\n<div class=\"page\" title=\"Page 2713\">Males: Testosterone</div>\n<div class=\"page\" title=\"Page 2713\">&nbsp;</div>\n<div class=\"page\" title=\"Page 2713\">Females:&nbsp;\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>For fertility: menopausal gonadotropins, hCG</p>\n<p>Post-menopausal women:&nbsp;Conjugated estrogen, progesterone</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>GH</td>\n<td>\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Somatotropin</p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>Vasopressin</td>\n<td>\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Intranasal desmopressin</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0226",
      "difficulty": "medium"
    },
    {
      "text": "A patient with acute hepatitis B has recovered from the infection. Identify the serological marker marked in the image:",
      "choices": [
        {
          "id": 1,
          "text": "Anti-HBc Ab"
        },
        {
          "id": 2,
          "text": "Anti-HBs Ab"
        },
        {
          "id": 3,
          "text": "Anti-HBe Ab"
        },
        {
          "id": 4,
          "text": "HBsAg"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>serological marker</strong> marked in the image which becomes <strong>detectable early</strong> in the infection and <strong>remains elevated </strong>for a<strong> long period</strong> <strong>after recovery</strong> from the infection is an <strong>anti-HBc </strong>antibody.</p>\n<p>Anti-HBc is demonstrable in serum within the first <strong>1&ndash;2 weeks</strong> <strong>after</strong> the appearance of <strong>HBsAg</strong>. It precedes detectable levels of anti-HBs by weeks to months.</p>\n<p><strong>IgM anti-HBcAg</strong> <strong>antibody</strong> is seen <strong>early</strong> in the infection for about <strong>6 months</strong> and indicates a <strong>recent infection</strong>. <strong>IgG anti-HBcAg antibody</strong> is seen later, <strong>after 6 months</strong>, and indicates <strong>remote infection</strong>.</p><hr><h3>Related Pearl: Interpretation of common serologic patterns in hepatitis B infection</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5552cae694994040b6b13be6442fc5adx1280x1466.JPEG\" alt=\"Pearl Image\"><p> </p>\n<table>\n<tbody>\n<tr>\n<td> <strong>Clinical Phases</strong></td>\n<td><span><strong>HBsAg</strong></span></td>\n<td><span><strong>Anti-HBs</strong></span></td>\n<td><span><strong>HBeAg</strong></span></td>\n<td><span><strong>Anti-HBe</strong></span></td>\n<td><span><strong>Anti-HBc</strong></span></td>\n<td><span><strong>HBV DNA</strong></span></td>\n</tr>\n<tr>\n<td><span>Acute HBV - Early-phase, high infectivity</span></td>\n<td>\n<p><span>+</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgM</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV -</span><span>Window phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgM</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV - recovery phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>+/-</span></td>\n</tr>\n<tr>\n<td><span>Chronic HBV, high infectivity</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Chronic HBV, low infectivity</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>IgG</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the recent past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the remote past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Post-vaccination</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f38348cf349a4c52b765156a02f3225e.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0227",
      "difficulty": "medium"
    },
    {
      "text": "The ECG of a pregnant lady having pre-eclampsia is shown below. Her vitals are stable. What is the best step in the management of the condition?",
      "choices": [
        {
          "id": 1,
          "text": "IV calcium"
        },
        {
          "id": 2,
          "text": "IV MgSO4"
        },
        {
          "id": 3,
          "text": "DC Shock"
        },
        {
          "id": 4,
          "text": "Synchronised cardioversion"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given ECG showing a <strong>wide QRS complex tachycardia</strong> with <strong>waxing and waning QRS amplitude points</strong> to the diagnosis of <strong>torsades des pointes</strong>. As the patient is <strong>hemodynamically stable</strong>, <strong>intravenous MgSO4</strong> is the treatment of choice.</p>\n<p>Polymorphic ventricular tachycardia (VT) has a continually <strong>changing QRS morphology</strong>. <strong>Polymorphic VT</strong> that occurs in individuals with <strong>congenital or acquired prolongation</strong> of <strong>QT interval</strong> is referred to as <strong>torsades des pointes</strong>. Patients present with near-syncope, syncope, or cardiac arrest.</p>\n<p><strong>IV MgSO4</strong> is highly effective for both <strong>treatment </strong>and the<strong> prevention</strong> <strong>of recurrence</strong> of <strong>long QT-related ventricular ectopic beats</strong> that trigger torsades des pointes.</p>\n<p>If <strong>magnesium</strong> alone is <strong>ineffective</strong>, <strong>isoproterenol infusion</strong> <strong>or pacing</strong>, to a rate of <strong>100-120 depolarization/minute</strong> usually suppresses VT recurrences.</p>\n<p>If the patient is <strong>hemodynamically unstable</strong>, then <strong>immediate defibrillation</strong> should be done.</p>\n<table>\n<tbody>\n<tr>\n<td>Synchronized cardioversion</td>\n<td>Defibrillation</td>\n</tr>\n<tr>\n<td>Used in <strong>unstable PSVT</strong>, atrial flutter, atrial fibrillation, and ventricular tachycardia <strong>with a pulse</strong></td>\n<td>Used in ventricular tachycardia <strong>without a pulse</strong>, and ventricular fibrillation.</td>\n</tr>\n<tr>\n<td>Shock is delivered in sync with the R wave (in absolute refractory period)</td>\n<td>Shock is delivered at any time during the cardiac cycle.</td>\n</tr>\n<tr>\n<td>Monophasic - 100 to 200J</td>\n<td>Monophasic - 360J</td>\n</tr>\n<tr>\n<td>Biphasic - 50 to 100J</td>\n<td>Biphasic - 120 to 200J</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: ECG patterns of various ventricular arrhythmias</h3><p>Ventricular tachycardia</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/097b95729fa14ac68da475ce6288a968x1088x570.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Polymorphic ventricular tachycardia associated with QTc prolongation- Torsades de pointes</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a8ebe0b5757c4efca4f5dd15c6d24e99x1268x324.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Ventricular flutter</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/666962cd0f424000b7e84123f719f120x502x282.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Ventricular fibrillation</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/25067efa869941baa6a40b54599b371ax1049x213.PNG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/47fe343facbb41888278414d974d3c09.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0228",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is the most common cause of infection post-solid organ transplantation in an Indian setting?",
      "choices": [
        {
          "id": 1,
          "text": "Cytomegalovirus"
        },
        {
          "id": 2,
          "text": "Varicella  zoster virus"
        },
        {
          "id": 3,
          "text": "Epstein-Barr virus"
        },
        {
          "id": 4,
          "text": "Herpes simplex virus"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The&nbsp;most common cause of infection post-solid organ transplantation in India is <strong>c</strong><strong>ytomegalovirus(CMV)</strong>. Epstein-Barr virus (EBV), Herpes, and varicella are also known to cause&nbsp;infection post-solid organ transplantation but to a lesser extent.</p>\n<p>CMV disease in recipients can present with fever, leukopenia, thrombocytopenia, malaise, and arthralgias.&nbsp;The diagnosis of CMV infection is established by&nbsp;nucleic acid testing (NAT)&nbsp;using the polymerase chain reaction (PCR).</p>\n<p>Management of this includes use of anti-viral drugs like <strong>ganciclovir</strong>, <strong>valganciclovir</strong>, <strong>foscarnet</strong>, <strong>cidofovir</strong> and <strong>intravenous immunoglobulins.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0229",
      "difficulty": "easy"
    },
    {
      "text": "Addison's disease is commonly associated with ____",
      "choices": [
        {
          "id": 1,
          "text": "Autoimmune adrenalitis"
        },
        {
          "id": 2,
          "text": "Adrenocortical carcinoma"
        },
        {
          "id": 3,
          "text": "Hypernephroma"
        },
        {
          "id": 4,
          "text": "Medullary carcinoma thyroid"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Primary adrenal insufficiency, also known as <strong>Addison&rsquo;s disease</strong>, is <strong>most commonly</strong> caused by <strong>autoimmune adrenalitis</strong>.</p>\n<p>Tuberculous adrenalitis is still a frequent cause of primary adrenal insufficiency in developing countries like India. It is characterized by the <strong>loss of glucocorticoid</strong>, <strong>mineralocorticoid</strong>, and <strong>adrenal androgen secretion</strong>.&nbsp;</p>\n<p><strong>Glucocorticoid deficiency</strong> results in fatigue, lack of energy, weight loss, fever, myalgia, <strong>normochromic anemia</strong>, and <strong>hypoglycemia</strong>. <strong>Mineralocorticoid deficiency</strong> is characterized by nausea, vomiting, <strong>low blood pressure</strong>, <strong>postural hypotension</strong>, <strong>salt craving</strong>, <strong>hyponatremia</strong>, and <strong>hyperkalemia</strong>. <strong>Adrenal androgen deficiency</strong> manifests as a lack of energy, <strong>dry itchy skin</strong>, <strong>loss of libido</strong>, and <strong>loss of axillary and pubic hair</strong> (in women).</p>\n<p><strong>Hyperpigmentation</strong> is seen in <strong>primary adrenal insufficiency</strong> due to <strong>excess proopiomelanocortin-derived peptides</strong>. <strong>Hyperpigmentation</strong> is <strong>not</strong> seen in <strong>secondary adrenal insufficiency</strong>.</p>\n<p>The <strong>diagnosis</strong> of adrenal insufficiency can be made with the <strong>short cosyntropin test</strong> (cortisol level &lt;450-500nmol/L sampled 30 to 60 minutes after ACTH stimulation is diagnostic of adrenal insufficiency).&nbsp;<strong>Plasma ACTH</strong>, <strong>plasma renin</strong>, and&nbsp;<strong>serum aldosterone</strong> can help <strong>differentiate primary from secondary</strong> causes. <strong>Primary adrenal insufficiency</strong> will show <strong>elevated ACTH</strong> and a compensatory <strong>elevation in renin</strong> levels due to <strong>decreased aldosterone</strong> in the body. In <strong>secondary adrenal insufficiency</strong>, <strong>ACTH is low</strong> with <strong>normal renin and aldosterone</strong>.</p>\n<p>Treatment includes glucocorticoid, mineralocorticoid, and adrenal androgen replacement.</p><p>Other options:</p>\n<p>Option B: Patients with <strong>adrenocortical carcinoma</strong> present with features of glucocorticoid and <strong>adrenal androgen excess</strong>, and <strong>not adrenal insufficiency</strong>.</p>\n<p>Options C and D: Hypernephroma and medullary carcinoma thyroid are not associated with Addison's disease.</p><hr><h3>Related Pearl: Causes of Adrenocortical Insufficiency</h3><p><strong>Primary</strong><strong>&nbsp;adrenal insufficiency:</strong></p>\n<ul>\n<li>Anatomical destruction of gland</li>\n<li>Autoimmune (Addison's disease)</li>\n<li>Isolated autoimmune adrenalitis (polygenic)</li>\n<li>Infections -&nbsp;HIV, tuberculosis, fungi</li>\n<li>Surgical removal</li>\n<li>Acute hemorrhagic necrosis (Waterhouse-Friderichsen syndrome)</li>\n<li>Amyloidosis, sarcoidosis, hemochromatosis</li>\n<li>Metastatic carcinoma</li>\n<li>Cytotoxic agents &ndash; mitotane</li>\n<li>Enzyme inhibitors &ndash; metyrapone, ketoconazole</li>\n<li>Congenital adrenal hypoplasia</li>\n<li>Autoimmune polyendocrinopathy syndrome type 1 (AIRE1 gene on 21q22)</li>\n<li>Autoimmune polyendocrinopathy syndrome type 2 (polygenic)</li>\n<li>X-linked adrenal hypoplasia (DAX1 gene on Xp21)</li>\n<li>Adrenoleukodystrophy (ALD gene on Xq28)</li>\n</ul>\n<p><strong>Secondary adrenal insufficiency:</strong></p>\n<p>Hypopituitarism due to hypothalamic or pituitary disease</p>\n<ul>\n<li>Neoplasm</li>\n<li>Infiltration (sarcoidosis)</li>\n<li>Infection (tuberculosis, pyogenic, fungal)</li>\n</ul>\n<p>Suppression of HPA axis</p>\n<ul>\n<li>By endogenous steroids from tumor</li>\n<li>By exogenous steroids</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0230",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is used in the treatment of hypercalcemia due to Vitamin D toxicity?",
      "choices": [
        {
          "id": 1,
          "text": "Dexamethasone"
        },
        {
          "id": 2,
          "text": "Hydroxychloroquine"
        },
        {
          "id": 3,
          "text": "Chloroquine"
        },
        {
          "id": 4,
          "text": "Ketoconazole"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In patients with <strong>hypercalcemia </strong>due to<strong> vitamin D toxicity</strong>, glucocorticoids like <strong>dexamethasone</strong> are the preferred therapy as they <strong>decrease 1,25 (OH2) vitamin D</strong> (calcitriol) production. This results in r<strong>educed intestinal calcium absorption</strong> and <strong>increased urinary excretion of calcium</strong>.</p>\n<p>Hydroxychloroquine, chloroquine, and ketoconazole may also decrease calcitriol production and are used occasionally. But the <strong>preferred therapy</strong> is <strong>steroids</strong>.</p>\n<p><strong>Vitamin D toxicity</strong> presents acutely with <strong>features of hypercalcemia</strong> such as <strong>confusion</strong>, <strong>polyuria</strong>, <strong>polydipsia</strong>, anorexia, vomiting, and muscle weakness. <strong>Chronic intoxication</strong> may cause <strong>nephrocalcinosis</strong>, bone demineralization, and pain.</p>\n<p>Lab features include <strong>elevated 25 (OH) vitamin D</strong>, <strong>high calcium</strong>, and <strong>suppressed PTH</strong>.</p>\n<p>Dexamethasone can also be used in the treatment of hypercalcemia caused by the humoral hypercalcemia of malignancy (due to PTHr) and sarcoidosis.</p><hr><h3>Related Pearl: Causes of Hypercalcemia</h3><ul>\n<li><strong>Parathyroid</strong>-Related\n<ul>\n<li>Primary hyperparathyroidism\n<ul>\n<li>Adenoma(s)</li>\n<li>Multiple endocrine neoplasia</li>\n<li>Carcinoma</li>\n</ul>\n</li>\n<li>Lithium therapy</li>\n<li>Familial hypocalciuric hypercalcemia</li>\n</ul>\n</li>\n<li><strong>Malignancy</strong>-Related\n<ul>\n<li>Solid tumour with metastases (breast)</li>\n<li>Solid tumour with humoral mediation of hypercalcemia (lung, kidney)</li>\n<li>Hematologic malignancies (multiple myeloma, lymphoma, leukemia)</li>\n</ul>\n</li>\n<li><strong>Vitamin</strong> <strong>D</strong>&ndash;Related\n<ul>\n<li>Vitamin D intoxication</li>\n<li>&uarr; 1,25(OH)2D :\n<ul>\n<li>Sarcoidosis and other granulomatous diseases</li>\n<li>Impaired 1,25(OH)2D metabolism due to 24-hydroxylase deficiency</li>\n</ul>\n</li>\n<li>Associated with <strong>high bone turnover</strong>\n<ul>\n<li>Hyperthyroidism</li>\n<li>Immobilization</li>\n<li>Thiazides</li>\n<li>Vitamin A intoxication</li>\n<li>Fat necrosis</li>\n</ul>\n</li>\n<li>Associated with <strong>renal failure</strong>\n<ul>\n<li>Severe secondary hyperparathyroidism</li>\n<li>Aluminium intoxication</li>\n<li>Milk-alkali syndrome</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0232",
      "difficulty": "medium"
    }
  ]
}